SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 68 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $47,000 | -43.4% | 39,743 | +56.6% | 0.00% | – |
| Q4 2021 | $83,000 | -17.8% | 25,386 | +12.0% | 0.00% | – |
| Q3 2021 | $101,000 | -18.5% | 22,675 | 0.0% | 0.00% | – |
| Q2 2021 | $124,000 | -17.9% | 22,675 | +12.6% | 0.00% | – |
| Q1 2021 | $151,000 | -27.4% | 20,133 | +5.1% | 0.00% | – |
| Q4 2020 | $208,000 | +58.8% | 19,150 | +29.7% | 0.00% | – |
| Q3 2020 | $131,000 | -16.6% | 14,766 | 0.0% | 0.00% | – |
| Q2 2020 | $157,000 | +42.7% | 14,766 | -20.6% | 0.00% | – |
| Q1 2020 | $110,000 | -14.1% | 18,594 | 0.0% | 0.00% | – |
| Q4 2019 | $128,000 | -9.2% | 18,594 | +36.7% | 0.00% | – |
| Q3 2019 | $141,000 | +11.9% | 13,602 | 0.0% | 0.00% | – |
| Q2 2019 | $126,000 | +32.6% | 13,602 | +31.2% | 0.00% | – |
| Q1 2019 | $95,000 | – | 10,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,726,603 | $15,228,000 | 10.06% |
| Flagship Pioneering Inc. | 3,204,437 | $29,673,000 | 1.28% |
| Redmile Group, LLC | 3,620,376 | $33,525,000 | 0.95% |
| ARK Investment Management | 3,791,756 | $35,112,000 | 0.88% |
| Nikko Asset Management Americas, Inc. | 2,987,763 | $27,667,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,268,946 | $11,750,000 | 0.42% |
| 683 Capital Management, LLC | 429,775 | $3,980,000 | 0.36% |
| EcoR1 Capital, LLC | 248,480 | $2,301,000 | 0.23% |
| ALGERT GLOBAL LLC | 17,920 | $166,000 | 0.06% |
| Baker Brothers Advisors | 974,835 | $9,027,000 | 0.06% |